We then analysed the correlation of tumour glutaminase activity with the expression of GLS1, GLS2, GCN5L1, c‐Myc and two major glutamine transporters downstream of c‐Myc, which are known to activate mTORC1 in HCC specimens.16 This evidence concerns the gene GLS2 and hepatocellular carcinoma.